Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms

被引：6

作者：

Mambet, Cristina ^{[1
,2
,3
]}

Babosova, Olga ^{[4
]}

Defour, Jean-Philippe ^{[2
,5
]}

Leroy, Emilie ^{[1
,2
]}

Necula, Laura ^{[3
]}

Stanca, Oana ^{[6
,7
]}

Tatic, Aurelia ^{[7
,8
]}

Berbec, Nicoleta ^{[6
,7
]}

Coriu, Daniel ^{[7
,8
]}

Belickova, Monika ^{[9
]}

Kralova, Barbora ^{[10
]}

Lanikova, Lucie ^{[4
]}

Vesela, Jitka ^{[9
]}

Pecquet, Christian ^{[1
,2
]}

Saussoy, Pascale ^{[5
]}

Havelange, Violaine ^{[11
]}

Diaconu, Carmen C. ^{[3
]}

Divoky, Vladimir ^{[10
]}

Constantinescu, Stefan N. ^{[1
,2
,3
]}

机构：

[1] Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium

[2] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium

[3] Stefan S Nicolau Inst Virol, Mol Profiling Myeloproliferat Neoplasms & Acute L, Bucharest, Romania

[4] Acad Sci Czech Republ, Inst Mol Genet, Dept Cell & Dev Biol, Prague, Czech Republic

[5] Catholic Univ Louvain, Clin Univ St Luc, Dept Biol Clin, Brussels, Belgium

[6] Coltea Clin Hosp, Dept Hematol, Bucharest, Romania

[7] Carol Davila Univ Med & Pharm, Dept Radiol Oncol & Hematol, Bucharest, Romania

[8] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania

[9] Inst Hematol & Blood Transfus, Prague, Czech Republic

[10] Palacky Univ, Fac Med & Dent, Dept Biol, Hnevotinska 3, CZ-77515 Olomouc, Czech Republic

[11] Clin Univ St Luc, Serv Hematol, Brussels, Belgium

来源：

BLOOD | 2018年 / 132卷 / 25期

关键词：

ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA;

D O I：

10.1182/blood-2018-04-843060

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2695 / 2699

页数：7

共 50 条

[1] Neutrophilia and the JAK2 V617F Mutation
Langabeer, Stephen E.
Haslam, Karl
PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
[2] V617F mutations of the JAK2 gene in hematological neoplasms
Mori, N.
Yoshinaga, K.
Tada, M.
Wang, Y-H.
Shiseki, M.
Motoji, T.
EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 81 - 81
[3] JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms
Choi, Daniel C.
Abu-Zeinah, Ghaith
Kermani, Pouneh
Messali, Nassima
Yabut, Maria Mia
Erdos, Katie
Scandura, Joseph M.
BLOOD, 2023, 142
[4] Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations
Yang, Hai-Su
CANCER BIOMARKERS, 2016, 17 (04) : 383 - 389
[5] Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
Pietra, Daniela
Li, Sai
Brisci, Angela
Passarnonti, Francesco
Rumi, Elisa
Theocharides, Alexandre
Ferrari, Maurizio
Gisslinger, Heinz
Kralovics, Robert
Cremonesi, Laura
Skoda, Radek
Cazzola, Mario
BLOOD, 2008, 111 (03) : 1686 - 1689
[6] JAK2 V617F mutation and the myeloproliferative disorders
Vainchenker, William
Casadevall, Nicole
HEMATOLOGIE, 2006, 12 (01): : 3 - 7
[7] The JAK2 V617F mutation in the myeloproliferative disorders
Sale, MA
Awan, A
Lucas, GS
Yin, JAL
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 33 - 33
[8] The V617F JAK2 mutation and the myeloproliferative disorders
Percy, MJ
McMullin, MF
HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
[9] Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
Gango, Ambrus
Mozes, Reka
Boha, Zsofia
Kajtar, Bela
Timar, Botond
Kiraly, Peter Attila
Kiss, Richard
Fesus, Viktoria
Nagy, Noemi
Demeter, Judit
Korosmezey, Gabor
Borbenyi, Zita
Marton, Imelda
Szoke, Anita
Masszi, Tamas
Farkas, Peter
Varkonyi, Judit
Plander, Mark
Posfai, Eva
Egyed, Miklos
Pal, Katalin
Radvanyi, Gaspar
Hamed, Aryan
Csomor, Judit
Matolcsy, Andras
Alpar, Donat
Bodor, Csaba
LEUKEMIA RESEARCH, 2018, 65 : 42 - 48
[10] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
Tanja Belcic Mikic
Tadej Pajic
Matjaz Sever
Scientific Reports, 9

← 1 2 3 4 5 →